NCT02621931 · Interventional trial
Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine
Overall registry status Completed
Phase 3
Conditions Migraine
Delaware Valley sites
- Teva Investigational Site 13554 · Philadelphia, PA · Philadelphia County
- Teva Investigational Site 13554 · Philadelphia, PA · Philadelphia County
- Teva Investigational Site 13591 · Jenkintown, PA · Montgomery County
First posted
Registry updated
Added to the directory